Ogawa S, Higuchi S, Yoshimoto Y, Hoshino M, Miura S, Hamada A, Watanabe H, Sakuma T, Hu K, Ogata S, Uchibe K, Fujimoto K, Yamamoto T, Okamoto T, Kunimatsu R, Sotomaru Y, Tanimoto K, Kondoh G, Komori T, Docheva D, Shukunami C. Functional impact of pathogenic mutations in the Runt homology domain of mouse Runx2 on skeletal and dental phenotypes in cleidocranial dysplasia Journal of Bone and Mineral Research. 2025.12; ( PubMed, DOI )

Yuki Adachi, Takuya Ono, Rei Noguchi, Julia Osaki, Shuhei Iwata, Taro Akiyama, Kazuyoshi Yanagihara, Shogo Nishino, Koichi Ogura, Akihiko Yoshida, Hideki Yokoo, Akira Kawai, Tadashi Kondo. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB11-C1 and NCC-GCTB12-C1. Human Cell. 2025.07; 38 (5): 128. ( PubMed, DOI )

Shuhei Iwata, Rei Noguchi, Julia Osaki, Yuki Adachi, Yomogi Shiota, Shuhei Osaki, Shogo Nishino, Akihiko Yoshida, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-EMC1-C1: a novel patient-derived cell line of extraskeletal myxoid chondrosarcoma. Human Cell. 2025.06; 38 (4): 122. ( PubMed, DOI )

Julia Osaki, Rei Noguchi, Takuya Ono, Yuki Adachi, Shuhei Iwata, Yomogi Shiota, Hiroya Kondo, Koichi Ogura, Shogo Nishino, Akihiko Yoshida, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-MLPS4-C1: a novel patient-derived cell line of myxoid liposarcoma. Human Cell. 2025.05; 38 (4): 109. ( PubMed, DOI )

Shuhei Iwata, Rei Noguchi, Julia Osaki, Yuki Adachi, Yomogi Shiota, Shuhei Osaki, Shogo Nishino, Akihiko Yoshida, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-PS2-C1: a novel cell line of high-grade pleomorphic spindle cell sarcoma, most consistent with myxofibrosarcoma. Human Cell. 2025.04; 38 (3): 93. ( PubMed, DOI )

Shuhei Iwata, Rei Noguchi, Julia Osaki, Yuki Adachi, Yomogi Shiota, Koichi Ogura, Shogo Nishino, Akihiko Yoshida, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-OS2-C1: a novel patient-derived cell line of osteosarcoma. Human Cell. 2025.04; 38 (3): 81. ( PubMed, DOI )

Rei Noguchi, Kazuyoshi Yanagihara, Yuki Iino, Teruo Komatsu, Takanori Kubo, Takuya Ono, Julia Osaki, Yuki Adachi, Shuhei Iwata, Yomogi Shiota, Tetsuo Seyama, Tadashi Kondo. Establishment and characterization of novel cancer cachexia-inducing cell line, Aku60GC, of scirrhous gastric cancer. Human Cell. 2025.04; 38 (3): 82. ( PubMed, DOI )

Shuhei Iwata, Takuya Ono, Rei Noguchi, Julia Osaki, Yuki Adachi, Yomogi Shiota, Suguru Fukushima, Shogo Nishino, Akihiko Yoshida, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-dCS2-C1: a novel patient-derived cell line of dedifferentiated chondrosarcoma. Human Cell. 2025.03; 38 (3): 78. ( PubMed, DOI )

Masato Hayashi, Rei Noguchi, Makoto Abe, Julia Osaki, Yuki Adachi, Shuhei Iwata, Kazuki Sasaki, Tadashi Kondo, Yuki Yoshimatsu. Gastric biopsy-derived cell line and its utility in assessing tumor cell drug sensitivity. Biomedical Research. 2025.01; 46 (1): 27-35. ( PubMed, DOI )

Yuki Adachi, Rei Noguchi, Julia Osaki, Takuya Ono, Taro Akiyama, Hiroya Kondo, Eisuke Kobayashi, Naoki Kojima, Akihiko Yoshida, Hideki Yokoo, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-GCTB10-C1: a novel cell line derived from a patient with recurrent giant cell tumor of bone. Human Cell. 2024.12; 38 (1): 29. ( PubMed, DOI )

Rei Noguchi, Takuya Ono, Julia Osaki, Yuki Adachi, Shuhei Iwata, Yomogi Shiota, Kazuyoshi Yanagihara, Shogo Nishino, Takaya Funada, Koichi Ogura, Akihiko Yoshida, Akira Kawai, Tadashi Kondo. Establishment and characterization of a novel patient-derived cell line from conventional central grade 3 chondrosarcoma, NCC-CS1-C1. Human Cell. 2024.12; 38 (1): 28. ( PubMed, DOI )

Shuhei Iwata, Takuya Ono, Rei Noguchi, Julia Osaki, Yuki Adachi, Yomogi Shiota, Shintaro Iwata, Shogo Nishino, Akihiko Yoshida, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-GCTB14-C1 and NCC-GCTB15-C1: two novel patient-derived cell lines of giant cell tumor of bone. Human Cell. 2024.11; 38 (1): 20. ( PubMed, DOI )

Rei Noguchi, Julia Osaki, Takuya Ono, Yuki Adachi, Shuhei Iwata, Yuki Yoshimatsu, Kazuki Sasaki, Akira Kawai, Tadashi Kondo. Pharmacoproteogenomic approach identifies on-target kinase inhibitors for cancer drug repositioning. In Vitro Cellular & Developmental Biology - Animal. 2024.10; 60 (10): 1200-1214. ( PubMed, DOI )

Yuki Adachi, Rei Noguchi, Julia Osaki, Takuya Ono, Shuhei Iwata, Taro Akiyama, Ryuto Tsuchiya, Yu Toda, Tetsuya Sekita, Shintaro Iwata, Eisuke Kobayashi, Naoki Kojima, Akihiko Yoshida, Hideki Yokoo, Akira Kawai, Tadashi Kondo. Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1. Human Cell. 2024.08; 37 (6): 1742-1750. ( PubMed, DOI )

Julia Osaki, Rei Noguchi, Takuya Ono, Yuki Adachi, Shuhei Iwata, Yu Toda, Takaya Funada, Shintaro Iwata, Naoki Kojima, Akihiko Yoshida, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-SS6-C1: a novel patient-derived cell line of synovial sarcoma. Human Cell. 2024.08; 37 (6): 1734-1741. ( PubMed, DOI )

Yuki Adachi, Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Julia Osaki, Takuya Ono, Shuhei Iwata, Taro Akiyama, Ryuto Tsuchiya, Yu Toda, Shin Ishihara, Koichi Ogura, Eisuke Kobayashi, Naoki Kojima, Akihiko Yoshida, Hideki Yokoo, Akira Kawai, Tadashi Kondo. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1. Human Cell. 2024.05; 37 (3): 874-885. ( PubMed, DOI )

Julia Osaki, Rei Noguchi, Kazuyoshi Yanagihara, Takuya Ono, Yuki Adachi, Shuhei Iwata, Yu Toda, Tetsuya Sekita, Eisuke Kobayashi, Naoki Kojima, Akihiko Yoshida, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma. Human Cell. 2024.05; 37 (3): 865-873. ( PubMed, DOI )

Takuya Ono, Rei Noguchi, Julia Osaki, Taro Akiyama, Yuki Adachi, Naoki Kojima, Yu Toda, Suguru Fukushima, Yuki Yoshimatsu, Akihiko Yoshida, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line. Human Cell. 2023.11; 37 (3): 854-864. ( PubMed, DOI )

Yuki Yoshimatsu, Rei Noguchi, Julia Osaki, Yooksil Sin, Ryuto Tsuchiya, Takuya Ono, Taro Akiyama, Yuki Adachi, Yoshikazu Tanzawa, Akihiko Yoshida, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma. Human Cell. 2023.10; 37 (1): 337-344. ( PubMed, DOI )

Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Julia Osaki, Takuya Ono, Yuki Adachi, Ryuto Tsuchiya, Yu Toda, Koichi Ogura, Naoki Kojima, Akihiko Yoshida, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation. Human Cell. 2023.07; 36 (6): 2187-2194. ( PubMed, DOI )

Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Julia Osaki, Takuya Ono, Yuki Adachi, Ryuto Tsuchiya, Yu Toda, Eisuke Kobayashi, Naoki Kojima, Akihiko Yoshida, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis. Human Cell. 2023.03; 36 (2): 847-853. ( PubMed, DOI )

Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Julia Osaki, Yuki Adachi, Takuya Ono, Ryuto Tsuchiya, Chiaki Sato, Shintaro Iwata, Naoki Kojima, Akihiko Yoshida, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-PLPS2-C1: a novel cell line of pleomorphic liposarcoma. Human Cell. 2023.01; 36 (1): 468-475. ( PubMed, DOI )

Julia Osaki, Satoshi Yamazaki, Atsuhiko Hikita, Kazuto Hoshi. Hematopoietic progenitor cells specifically induce a unique immune response in dental pulp under conditions of systemic inflammation. Heliyon. 2022.02; 8 (2): e08904. ( PubMed, DOI )

Julia Osaki, Kazuyoshi Yanagihara, Ikumi Fujita, Masaki Matsumoto, Sumio Otsuki, Tadashi Kondo. Cancer Cachexia Research Using Patient-Derived Models: A Multi-Omics Approach for the Molecular Background of Disease and Identifying Therapeutic Candidates. Comparative Medicine Symposium 2025.10.20 Seoul, Republic of Korea

Julia Osaki, Kazuyoshi Yanagihara, Ikumi Fujita, Masaki Matsumoto, Sumio Otsuki, Tadashi Kondo. Cancer Cachexia Research Using Patient-Derived Models: A Multi-Omics Approach for the Molecular Background of Disease and Novel Therapeutic Strategies. Korean Human Proteome Organization 2025 2025.10.15 Busan, Republic of Korea

Yuki Yoshimatsu, Rei Noguchi, Tara Akiyama, Ryuto Tsuchiya, Yooksil Sin, Takuya Ono, Julia Osaki, Yuki Adachi, Shuhei Iwata, Akihiko Yoshida, Akira Kawai, Tadashi Kondo. Establishment and Application of Cancer Models for Translational Research. Unite Explores Cancer Conference 2025.08.07 Munich, Germany

Yuki Yoshimatsu, Rei Noguchi, Tara Akiyama, Ryuto Tsuchiya, Yooksil Sin, Takuya Ono, Julia Osaki, Yuki Adachi, Shuhei Iwata, Akihiko Yoshida, Akira Kawai, Tadashi Kondo. Precision Medicine for Rare Cancers. 4th International Conference on Cancer Science and Therapy 2025.05.12 Dubai, United Arab Emirates

岩田秀平、野口玲、大崎珠理亜、塩田よもぎ、安達雄輝、後藤詩織、岩田慎太郎、大鳥精司、川井章、近藤格. Proteogenomic analysis revealed prognosis biomarker and therapeutic targets in sarcomas. 第75回日本電気泳動学会 2024.12.06 神奈川

Shuhei Iwata, Shungo Adachi, Rei Noguchi, Yuki Adachi, Julia Osaki, Yomogi Shiota, Koichi Ogura, Shintaro Iwata, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Proteogenomic analysis revealed prognosis biomarker and therapeutic targets in sarcomas. HUPO 2024 World Congress 2024.10.20 Dresden, Germany

Yomogi Shiota, Julia Osaki, Rei Noguchi, Shuhei Iwata, Yuki Adachi, Daiki Kato, Tatsuya Usui, Tadashi Kondo. Integrative study of patient-derived in-vitro model toward pharmaco-proteogenomics. HUPO 2024 World Congress 2024.10.20 Dresden, Germany

Julia Osaki, Rei Noguchi, Yuki Adachi, Shuhei Iwata, Yomogi Shiota, Kazuki Sasaki, Masaki Matsumoto, Tadashi Kondo. Pharmaco-proteogenomics for synovial sarcoma towards novel therapy. HUPO 2024 World Congress 2024.10.20 Dresden, Germany

安達雄輝、野口玲、大崎珠理亜、岩田秀平、谷野美智枝、佐々木一樹、大槻純男、横尾英樹、近藤格. Molecular Mechanisms of Postoperative Recurrence in Hepatocellular Carcinoma: Proteomic Analysis of FFPE Samples. 第83回日本癌学会学術総会 2024.09.19 福岡

野口玲、吉松有紀、大崎珠理亜、安達雄輝、小野拓也、秋山太郎、柳原五吉、川井章、近藤格. Drug discovery for sarcoma: genomic analysis and drug screening in patient-derived cell lines. 第83回日本癌学会学術総会 2024.09.19 福岡

Rei Noguchi, Julia Osaki, Taro Akiyama, Takuya Ono, Yuki Adachi, Yuki Yoshimatsu, Kazuyoshi Yanagihara, Akihiko Yoshida, Akira Kawai, Tadashi Kondo. Drug repositioning for giant cell tumor of bone with multi-omics analysis: models, genome, kinome, and drug screening. 第82回日本癌学会学術総会 2023.09.21 パシフィコ横浜 神奈川

Rei Noguchi, Julia Osaki, Taro Akiyama, Takuya Ono, Yuki Adachi, Kazuyoshi Yanagihara, Yuki Yoshimatsu, Akihiko Yoshida, Akira Kawai, Tadashi Kondo. Drug identification using genomic feature, kinase activity profiles, and drug screening with patient-derived models in giant cell tumor of bone. HUPO 2023 World Congress 2023.09.17 Busan, Republic of Korea

Yuki Adachi, Rei Noguchi, Takuya Ono, Julia Osaki, Kazuyoshi Yanagihara, Yuki Yoshimatsu, Hideki Yokoo, Sumio Ohtsuki, Tadashi Kondo. Comprehensive Proteomic Analysis of FFPE Specimens in Hepatocellular Carcinoma for Investigating Recurrence Mechanism. HUPO 2023 World Congress 2023.09.17 Busan, Republic of Korea

Taro Akiyama, Rei Noguchi, Julia Osaki, Takuya Ono, Yuki Adachi, Ryuto Tsuchiya, Shuhei Iwata, Akihiko Yoshida, Yuki Yoshimatsu, Akira Kawai, Yoshio Kodera, Tadashi Kondo. Global proteome expression study of patient-derived pleomorphic sarcoma cell-lines toward optimization of therapeutic strategy using trabectedin and eribulin. HUPO 2023 World Congress 2023.09.17 Busan, Republic of Korea

Takuya Ono, Rei Noguchi, Julia Osaki, Yuki Adachi, Taro Akiyama, Yuki Yoshimatsu, Tadashi Kondo. Proteomic analysis to identify the molecular differences between dermatofibrosarcoma protuberans and fibrosarcomatous dermatofibrosarcoma protuberans. HUPO 2023 World Congress 2023.09.17 Busan, Republic of Korea

Julia Osaki, Rei Noguchi, Takuya Ono, Yuki Adachi, Kazuyoshi Yanagihara, Yuki Yoshimatsu, Tsutomu Ohta, Tadashi Kondo. Development of treatments for CIC-rearranged sarcomas: Multiplex kinase activity analysis and drug screening using patient-derived cancer models. HUPO 2023 World Congress 2023.09.17 Busan, Republic of Korea

Takuya Ono, Rei Noguchi, Yooksil Sin, Julia Osaki, Taro Akiyama, Yuki Adachi, Airi Nakano, Kazuyoshi Yanagihara, Keigo Amari, Yutaka Sugihara, Yuki Yoshimatsu, Yoshio Kodera, Tadashi Kondo. Histological and proteomic analysis for the evaluation of perfusion culture system of spheroids. HUPO 2022 Congress 2022.12.04 Cancun, Mexico

Yuki Adachi, Rei Noguchi, Yooksil Sin, Takuya Ono, Taro Akiyama, Julia Osaki, Yuki Yoshimatsu, Yutaka Sugihara, Kazuyoshi Yanagihara, Hideki Yokoo, Tadashi Kondo. Proteomic Analysis of the Molecular Biological Changes Induced by Fatty Acid-Binding Protein-5 inhibitor in Hepatocellular Carcinoma. HUPO 2022 Congress 2022.12.04 Cancun, Mexico

Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Takuya Ono, Julia Osaki, Yuki Adachi, Kazuyoshi Yanagihara, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Screening of 214 antitumor agents using cell lines derived from seven patients with giant cell tumor of bone. 第37回日本整形外科学会基礎学術集会 2022.10.13 シーガイアコンベンションセンター、宮崎

Yooksil Sin, Rei Noguchi, Ryuto Tsuchiya, Julia Osaki, Takuya Ono, Taro Akiyama, Yuki Adachi, Kazuyoshi Yanagihara, Jun Sugaya, Akira Kawai, Yuki Yoshimatsu, Tadashi Kondo. Establishment and characterization of a novel cell line, NCC-DDLPS5-C1, a novel patient-derived cell line of dedifferentiated liposarcoma. 第81回日本癌学会学術総会 2022.09.29 パシフィコ横浜、神奈川

Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Takuya Ono, Julia Osaki, Yuki Adachi, Kazuyoshi Yanagihara, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Screening of 214 antitumor agents using cell lines derived from seven patients with giant cell tumor of bone. 第81回日本癌学会学術総会 2022.09.29 パシフィコ横浜、神奈川

Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Takuya Ono, Julia Osaki, Yuki Adachi, Kazuyoshi Yanagihara, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Screening of 214 antitumor agents using cell lines derived from seven patients with giant cell tumor of bone. 第81回日本癌学会学術総会 2022.09.29 パシフィコ横浜、神奈川

Takuya Ono, Rei Noguchi, Yooksil Sin, Julia Osaki, Taro Akiyama, Yuki Adachi, Airi Nakano, Kazuyoshi Yanagihara, Suguru Fukushima, Akira Kawai, Yuki Yoshimatsu, Tadashi Kondo. Establishment and characterization of a novel patient-derived cell line from dermatofibrosarcoma protuberans. 第81回日本癌学会学術総会 2022.09.29 パシフィコ横浜、神奈川

Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Takuya Ono, Julia Osaki, Yuki Adachi, Kazuyoshi Yanagihara, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Screening of 214 antitumor agents using cell lines derived from seven patients with giant cell tumor of bone. 第39回日本プロテオーム学会 2022.08.08 北里大学 相模原キャンパス、神奈川

Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Takuya Ono, Julia Osaki, Yuki Adachi, Kazuyoshi Yanagihara, Seiji Ohtori, Akira Kawai, Tadashi Kondo. Establishment and characterization of NCC-MRT1-C1: the first cell line of malignant rhabdoid tumor of soft tissue. 第55回日本整形外科学会骨・軟部腫瘍学術集会 2022.07.14 タワーホール船堀+Web開催